BioInfra Life Science Inc. (XKON:266470)

BioInfra Life Science Statistics

Total Valuation

XKON:266470 has a market cap or net worth of KRW 7.06 billion.

Market Cap	7.06B
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

XKON:266470 has 21.67 million shares outstanding.

Current Share Class	21.67M
Shares Outstanding	21.67M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+0.09%
Owned by Insiders (%)	34.72%
Owned by Institutions (%)	n/a
Float	7.94M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.97
PB Ratio	-5.86
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.67

Current Ratio	1.67
Quick Ratio	1.66
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-3.54
Interest Coverage	-12.02

Financial Efficiency

Return on equity (ROE) is -746.61% and return on invested capital (ROIC) is -37.22%.

Return on Equity (ROE)	-746.61%
Return on Assets (ROA)	-28.10%
Return on Invested Capital (ROIC)	-37.22%
Return on Capital Employed (ROCE)	-57.93%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.23
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -28.93% in the last 52 weeks. The beta is -0.18, so XKON:266470's price volatility has been lower than the market average.

Beta (5Y)	-0.18
52-Week Price Change	-28.93%
50-Day Moving Average	193.42
200-Day Moving Average	276.26
Relative Strength Index (RSI)	70.26
Average Volume (20 Days)	12,518

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, XKON:266470 had revenue of KRW 1.78 billion and -3.59 billion in losses. Loss per share was -266.28.

Revenue	1.78B
Gross Profit	825.48M
Operating Income	-3.55B
Pretax Income	-3.59B
Net Income	-3.59B
EBITDA	-3.18B
EBIT	-3.55B
Loss Per Share	-266.28

Balance Sheet

The company has 7.49 billion in cash and 10.46 billion in debt, giving a net cash position of -2.97 billion or -137.09 per share.

Cash & Cash Equivalents	7.49B
Total Debt	10.46B
Net Cash	-2.97B
Net Cash Per Share	-137.09
Equity (Book Value)	-1.21B
Book Value Per Share	-102.70
Working Capital	3.58B

Cash Flow

In the last 12 months, operating cash flow was -2.87 billion and capital expenditures -81.61 million, giving a free cash flow of -2.95 billion.

Operating Cash Flow	-2.87B
Capital Expenditures	-81.61M
Free Cash Flow	-2.95B
FCF Per Share	-136.38

Margins

Gross margin is 46.40%, with operating and profit margins of -199.78% and -202.04%.

Gross Margin	46.40%
Operating Margin	-199.78%
Pretax Margin	-202.04%
Profit Margin	-202.04%
EBITDA Margin	-178.62%
EBIT Margin	-199.78%
FCF Margin	n/a

Dividends & Yields

XKON:266470 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	2.59%
Shareholder Yield	2.59%
Earnings Yield	-50.88%
FCF Yield	-41.84%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

XKON:266470 has an Altman Z-Score of -4.65 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.65
Piotroski F-Score	1